Synopsys INC Form 4 insider transactions

Aart de Geus, Executive Chair of Synopsys, reports the exercise of stock options and sale of shares, along with a transfer of shares between trusts.

Aart de Geus, Executive Chair of Synopsys, exercised stock options and sold shares on July 10th and 11th, 2024, according to a Form 4 filing with the SEC.

Aart de Geus, Executive Chair of Synopsys, exercised stock options and sold shares on July 5th and July 8th, 2024, according to a Form 4 filing with the SEC.

Aart de Geus, Executive Chair of Synopsys, exercised stock options and sold shares on July 2nd and 3rd, 2024, according to a Form 4 filing with the SEC.

Aart de Geus, Executive Chair of Synopsys, exercised stock options and sold shares in multiple transactions on June 28, 2024, and July 1, 2024, according to a Form 4 filing with the SEC.

Aart de Geus, Executive Chair of Synopsys, exercised stock options and sold shares of common stock on June 26 and 27, 2024, according to a Form 4 filing with the SEC.

Aart de Geus, Executive Chair of Synopsys, exercised stock options and sold shares of common stock on June 24 and 25, 2024, according to a Form 4 filing with the SEC.

Richard S. Mahoney, Chief Revenue Officer of Synopsys Inc., reported the sale of 3,316 shares of common stock on June 18, 2024, at a price of $611.41 per share.

Richard Mahoney, Chief Revenue Officer of Synopsys Inc., reported the disposition and acquisition of common stock and restricted stock units to cover tax obligations.

John F. Runkel, Jr., GC & Corporate Secretary of Synopsys Inc., reports exercising stock options and selling shares under a pre-arranged Rule 10b5-1 trading plan.

Director Mercedes Johnson transferred 1,697 shares of Synopsys Inc. common stock into the Mercedes Johnson Trust on May 28, 2024.

Synopsys CEO Sassine Ghazi exercised stock options and sold shares on May 24, 2024, according to a Form 4 filing with the SEC.

John F. Runkel, Jr., GC & Corporate Secretary of Synopsys Inc., reports exercising stock options and selling shares on May 24, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Synopsys' acquisition of Ansys faces a potential delay due to a notification requirement from Chinese regulators, with the transaction still expected to close in the first half of 2025.

Synopsys' acquisition of Ansys may be delayed as Chinese regulators acknowledge the transaction but require notification.

Ansys supplements its proxy statement with additional disclosures to address stockholder demands challenging the adequacy of information provided in connection with the proposed merger with Synopsys.

Director Luis Borgen reports acquisition of 356 shares of Synopsys common stock through an automatic award under the company's equity incentive plan.

Director Roy Vallee reports acquisition of 356 shares of Synopsys Inc. stock and indirect ownership of 20,000 shares through a partnership.

Director John Schwarz reports acquisition of 356 shares of Synopsys common stock on April 10, 2024, through an automatic award under the company's 2017 Non-Employee Directors Equity Incentive Plan.

Director Jeannine P. Sargent reports acquisition of 356 shares of Synopsys common stock and indirect ownership through a family trust.

Director Robert G. Painter reports acquisition of 356 shares of Synopsys Inc. common stock through an automatic award under the company's equity incentive plan.

Director Mercedes Johnson reports acquisition of common stock and disposition of shares held by a trust.

Director Bruce R. Chizen reports acquisition of 356 shares of Synopsys common stock on April 10, 2024, through an automatic award under the company's 2017 Non-Employee Directors Equity Incentive Plan.

Director Janice Chaffin reports acquisition of 356 shares of Synopsys Inc. common stock through an automatic award under the company's 2017 Non-Employee Directors Equity Incentive Plan.

Director Marc N. Casper reports acquiring 356 shares of Synopsys Inc. common stock at $0.00 price, increasing direct holdings to 2,092 shares.

John F. Runkel Jr., GC & Corporate Secretary of Synopsys Inc., reports the sale of 5,319 shares of common stock on April 3, 2024.

Director Marc N. Casper reports purchasing Synopsys Inc. (SNPS) stock on March 25, 2024.

Synopsys hosted an investor day on March 20, 2024, and announced the initiation of a sale process for its Software Integrity business following a strategic portfolio review.

Synopsys and Ansys have agreed to appoint Ansys' current CEO, Dr. Ajei Gopal, to Synopsys' board of directors upon the completion of Synopsys' acquisition of Ansys.

Aart de Geus, Executive Chair of Synopsys, reports the acquisition and disposition of common stock and restricted stock units on March 15, 2024.